Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0RKL market cap is 3.35B. The company's latest EPS is SEK 5.4438 and P/E is 6.15.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 179.86M | 258.39M | 415.29M | 597.54M | 822.42M |
| Operating Income | -44.19M | -18.74M | 4.46M | 5.4M | 88.35M |
| Net Income | -43.74M | 8.15M | 18.43M | 91.82M | 172.18M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 1.15B | 1.54B | 1.73B | 2.2B | 2.4B |
| Total Liabilities | 141.85M | 257.15M | 302.95M | 250.57M | 245.97M |
| Total Equity | 1.01B | 1.29B | 1.43B | 1.95B | 2.16B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -12.27M | -12.06M | 27.86M | 46.29M | 111.29M |
| Investing | -266.53M | -187.7M | -197.62M | -161.62M | -243.81M |
| Financing | 482.77M | 234.61M | -6.84M | 418.55M | -10.9M |
| Market Cap | 3.35B |
| Price to Earnings Ratio | 6.15 |
| Price to Sales Ratio | 1.29 |
| Price to Cash Ratio | 2.55 |
| Price to Book Ratio | 0.49 |
| Dividend Yield | - |
| Shares Outstanding | 31.63M |
| Average Volume (1 week) | 33.43k |
| Average Volume (1 Month) | 9.68k |
| 52 Week Change | 0.00% |
| 52 Week High | 106.00 |
| 52 Week Low | 106.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Xvivo Perfusion Ab |
| Address |
massans gata 10 goteborg SE-400 14 |
| Website | https://www.xvivoperfusion.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
